business / news / / scanx.trade
Sanofi Consumer Healthcare India Limited has announced robust Q4 financial results, demonstrating strong operational performance across key metrics.
Sanofi Consumer Healthcare India's Q4 net profit rose 35.6% to ₹678 million year-over-year.
KEY POINTS
- Domestic sales grew 15.5%, while export sales surged 144.4% on a low base this quarter.
- Product relaunches of Combiflam Suspension, Allegra Suspension, and Depura Kids significantly boosted domestic sales.
- The company recognized a ₹24 million expense due to new Indian Labour Codes affecting employee benefits.
- All four material related party and remuneration resolutions were approved with over 99.9% shareholder support.
COMPANIES
Summarized by Newsio from scanx.trade. How we summarize →